Emerging opportunities in the cancer biomarkers market include the growth of personalized oncology, non-invasive diagnostics, ...

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

CRISPR-Cas12a technology is emerging as a powerful tool for infectious disease diagnostics, combining precision with speed and portability. New one-pot and amplification-free systems are delivering ...

Health workers in the district are helping HIV-positive mothers give birth to HIV-negative babies through improved access to ...

The study offers a valuable resource and integrates multiple complementary datasets to provide insights into regulatory mechanisms, although the conceptual advances are moderate and the central ...

The global dermatomycoses market is poised for significant growth, fueled by rising superficial fungal infections, increased hygiene awareness, and a growing immunocompromised population. These fungal ...

For years, dahlia growers and the labs that test their tubers have treated Dahlia mosaic virus (DMV) and Dahlia common mosaic ...

A 13-year-old boy with no history presented after 4 days of progressively worsening whole body rash.Nine days before ...

AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease ...

As Sujan Manna searched for tiny, spherical gold nanoparticles against a dark-field backdrop, he came across an unexpected ...

MIT postdoctoral associate Arunav Kumar discusses his work on magnetohydrodynamic stability, plasma control in tokamaks, and ...

A new DNA testing method confirming the sex of newly hatched birds within an hour is improving the recovery efforts for two ...